Predicting cerebrospinal fluid α-synuclein seed amplification assay positivity in borderline hyposmia
Authors:
- Yu-Xiang JiaoYJYu-Xiang Jiao
- Pei-Wen HanPHPei-Wen Han
- Peng-Bo YangPYPeng-Bo Yang
- Shuang HeSHShuang He
- Xiao LiuXLXiao Liu
- Chen-Hong LiCLChen-Hong Li
- Jie-Wen ZhangJZJie-Wen Zhang
- Shuai ChenSCShuai Chen
- 5 November 2026
- journal article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 154
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Consistency of Serial Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay Results in the Parkinson's Precision Medicine InitiativeMovement Disorders, 2026
- Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior DisorderAnnals of Neurology, 2025
- Predicting CSF α-Synuclein Seed Amplification Assay Status From Demographics and Clinical DataNeurology Open Access, 2025
- α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson DiseaseNeurology, 2025
- Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional studyEBioMedicine, 2025
- Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha‐Synuclein DiseaseAnnals of Neurology, 2024
- A biological definition of neuronal α-synuclein disease: towards an integrated staging system for researchThe Lancet Neurology, 2024
- Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional studyThe Lancet Neurology, 2023
- Update of the MDS research criteria for prodromal Parkinson's diseaseMovement Disorders, 2019
- Olfaction in Parkinson's disease and related disordersNeurobiology of Disease, 2012